MT1X was demonstrated to be a tumor suppressor that suppresses tumor growth and metastasis in vivo and induces cell cycle arrest and apoptosis by repressing the NF-κB signaling pathway in HCC (Liu et al., 2018b). Here, NFKB1 is linked to hepatocellular carcinoma.